Appleton Partners Inc Merck & Co., Inc. Transaction History

Appleton Partners Inc

  • $1.36 Billion
  • Q3 2024

A detailed history of Appleton Partners Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Appleton Partners Inc holds 112,112 shares of MRK stock, worth $10.9 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
112,112
Previous 104,864 6.91%
Holding current value
$10.9 Million
Previous $13 Million 1.93%
% of portfolio
0.94%
Previous 1.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024
BUY
$111.15 - $128.97 $805,615 - $934,774
7,248 Added 6.91%
112,112 $12.7 Million
Q2 2024

Jul 02, 2024
BUY
$123.8 - $132.96 $86,907 - $93,337
702 Added 0.67%
104,864 $13 Million
Q1 2024

Apr 01, 2024
SELL
$113.24 - $131.95 $62,508 - $72,836
-552 Reduced 0.53%
104,162 $13.7 Million
Q4 2023

Jan 02, 2024
BUY
$100.18 - $109.02 $664,794 - $723,456
6,636 Added 6.77%
104,714 $11.4 Million
Q3 2023

Oct 03, 2023
BUY
$102.95 - $114.33 $1.15 Million - $1.28 Million
11,153 Added 12.83%
98,078 $10.1 Million
Q2 2023

Jul 10, 2023
BUY
$108.61 - $118.38 $2.44 Million - $2.66 Million
22,479 Added 34.88%
86,925 $10 Million
Q1 2023

Apr 10, 2023
BUY
$102.94 - $114.86 $904,842 - $1.01 Million
8,790 Added 15.79%
64,446 $6.86 Million
Q4 2022

Jan 19, 2023
BUY
$87.44 - $112.11 $858,485 - $1.1 Million
9,818 Added 21.42%
55,656 $6.18 Million
Q3 2022

Oct 27, 2022
BUY
$84.53 - $94.96 $686,552 - $771,265
8,122 Added 21.53%
45,838 $3.95 Million
Q2 2022

Jul 08, 2022
BUY
$83.49 - $94.64 $130,661 - $148,111
1,565 Added 4.33%
37,716 $3.44 Million
Q1 2022

Apr 05, 2022
SELL
$73.51 - $82.4 $382,252 - $428,480
-5,200 Reduced 12.58%
36,151 $2.97 Million
Q4 2021

Feb 03, 2022
BUY
$72.28 - $90.54 $146,656 - $183,705
2,029 Added 5.16%
41,351 $3.17 Million
Q3 2021

Oct 14, 2021
SELL
$71.68 - $78.83 $50,749 - $55,811
-708 Reduced 1.77%
39,322 $2.95 Million
Q2 2021

Jul 07, 2021
SELL
$70.31 - $77.77 $13,429 - $14,854
-191 Reduced 0.47%
40,030 $3.11 Million
Q1 2021

Apr 19, 2021
SELL
$68.86 - $81.11 $86,419 - $101,793
-1,255 Reduced 3.03%
40,221 $3.1 Million
Q4 2020

Jan 19, 2021
SELL
$71.77 - $79.65 $32,009 - $35,523
-446 Reduced 1.06%
41,476 $3.39 Million
Q3 2020

Oct 14, 2020
SELL
$73.18 - $82.95 $40,102 - $45,456
-548 Reduced 1.29%
41,922 $3.48 Million
Q2 2020

Aug 14, 2020
SELL
$70.42 - $80.13 $17,675 - $20,112
-251 Reduced 0.59%
42,470 $3.28 Million
Q1 2020

May 04, 2020
SELL
$63.36 - $87.82 $22,049 - $30,561
-348 Reduced 0.81%
42,721 $3.29 Million
Q4 2019

Jan 13, 2020
SELL
$77.58 - $87.54 $115,826 - $130,697
-1,493 Reduced 3.35%
43,069 $3.92 Million
Q3 2019

Nov 04, 2019
BUY
$76.08 - $82.93 $9,129 - $9,951
120 Added 0.27%
44,562 $3.75 Million
Q2 2019

Jul 25, 2019
SELL
$69.84 - $81.59 $37,224 - $43,487
-533 Reduced 1.19%
44,442 $3.73 Million
Q1 2019

Apr 17, 2019
BUY
$69.58 - $79.36 $131,575 - $150,069
1,891 Added 4.39%
44,975 $3.74 Million
Q4 2018

Jan 17, 2019
SELL
$65.24 - $75.71 $29,553 - $34,296
-453 Reduced 1.04%
43,084 $3.29 Million
Q3 2018

Oct 09, 2018
BUY
$57.69 - $67.84 $118,552 - $139,411
2,055 Added 4.95%
43,537 $3.09 Million
Q2 2018

Aug 08, 2018
BUY
$50.83 - $59.72 $249,117 - $292,687
4,901 Added 13.4%
41,482 $2.52 Million
Q1 2018

Apr 11, 2018
BUY
$50.96 - $59.23 $261,068 - $303,435
5,123 Added 16.29%
36,581 $1.99 Million
Q4 2017

Jan 12, 2018
BUY
$51.62 - $61.64 $148,975 - $177,893
2,886 Added 10.1%
31,458 $1.77 Million
Q3 2017

Oct 12, 2017
BUY
$58.67 - $63.13 $1.68 Million - $1.8 Million
28,572
28,572 $1.83 Million

Others Institutions Holding MRK

# of Institutions
3,819
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Appleton Partners Inc Portfolio

Follow Appleton Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email